270 related articles for article (PubMed ID: 21459096)
21. Natriuretic peptide receptors and neutral endopeptidase in mediating the renal actions of a new therapeutic synthetic natriuretic peptide dendroaspis natriuretic peptide.
Chen HH; Lainchbury JG; Burnett JC
J Am Coll Cardiol; 2002 Sep; 40(6):1186-91. PubMed ID: 12354448
[TBL] [Abstract][Full Text] [Related]
22. Biochemical analysis of neutral endopeptidase activity reveals independent catabolism of atrial and brain natriuretic peptide.
Walther T; Stepan H; Pankow K; Becker M; Schultheiss HP; Siems WE
Biol Chem; 2004 Feb; 385(2):179-84. PubMed ID: 15101560
[TBL] [Abstract][Full Text] [Related]
23. cGMP-dependent and -independent inhibition of a K+ conductance by natriuretic peptides: molecular and functional studies in human proximal tubule cells.
Hirsch JR; Meyer M; Mägert HJ; Forssmann WG; Mollerup S; Herter P; Weber G; Cermak R; Ankorina-Stark I; Schlatter E; Kruhøffer M
J Am Soc Nephrol; 1999 Mar; 10(3):472-80. PubMed ID: 10073597
[TBL] [Abstract][Full Text] [Related]
24. Arg13 of B-type natriuretic Peptide reciprocally modulates binding to guanylyl cyclase but not clearance receptors.
Dickey DM; Barbieri KA; McGuirk CM; Potter LR
Mol Pharmacol; 2010 Sep; 78(3):431-5. PubMed ID: 20530652
[TBL] [Abstract][Full Text] [Related]
25. Cardiac fibrosis in end-stage human heart failure and the cardiac natriuretic peptide guanylyl cyclase system: regulation and therapeutic implications.
Ichiki T; Schirger JA; Huntley BK; Brozovich FV; Maleszewski JJ; Sandberg SM; Sangaralingham SJ; Park SJ; Burnett JC
J Mol Cell Cardiol; 2014 Oct; 75():199-205. PubMed ID: 25117468
[TBL] [Abstract][Full Text] [Related]
26. Natriuretic peptide pathways in heart failure: further therapeutic possibilities.
Sangaralingham SJ; Kuhn M; Cannone V; Chen HH; Burnett JC
Cardiovasc Res; 2023 Feb; 118(18):3416-3433. PubMed ID: 36004816
[TBL] [Abstract][Full Text] [Related]
27. Vascular effects of natriuretic peptides in healthy men.
Komarek M; Bernheim A; Schindler R; Steden R; Kiowski W; Brunner-La Rocca HP
J Cardiovasc Pharmacol Ther; 2004 Dec; 9(4):263-70. PubMed ID: 15678245
[TBL] [Abstract][Full Text] [Related]
28. Electrophysiological effects of natriuretic peptides in the heart are mediated by multiple receptor subtypes.
Moghtadaei M; Polina I; Rose RA
Prog Biophys Mol Biol; 2016 Jan; 120(1-3):37-49. PubMed ID: 26701223
[TBL] [Abstract][Full Text] [Related]
29. Antihypertrophic actions of the natriuretic peptides in adult rat cardiomyocytes: importance of cyclic GMP.
Rosenkranz AC; Woods RL; Dusting GJ; Ritchie RH
Cardiovasc Res; 2003 Feb; 57(2):515-22. PubMed ID: 12566124
[TBL] [Abstract][Full Text] [Related]
30. The renal and cardiovascular effects of natriuretic peptides.
Wong PC; Guo J; Zhang A
Adv Physiol Educ; 2017 Jun; 41(2):179-185. PubMed ID: 28377431
[TBL] [Abstract][Full Text] [Related]
31. Characterization and functional expression of the natriuretic peptide system in human lens epithelial cells.
Cammarata PR; Braun B; Dimitrijevich SD; Pack J
Mol Vis; 2010 Apr; 16():630-8. PubMed ID: 20700369
[TBL] [Abstract][Full Text] [Related]
32. Natriuretic peptides like NO facilitate cardiac vagal neurotransmission and bradycardia via a cGMP pathway.
Herring N; Zaman JA; Paterson DJ
Am J Physiol Heart Circ Physiol; 2001 Dec; 281(6):H2318-27. PubMed ID: 11709398
[TBL] [Abstract][Full Text] [Related]
33. Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11.
Kenny AJ; Bourne A; Ingram J
Biochem J; 1993 Apr; 291 ( Pt 1)(Pt 1):83-8. PubMed ID: 8097089
[TBL] [Abstract][Full Text] [Related]
34. Differential regulation of membrane guanylyl cyclases in congestive heart failure: natriuretic peptide receptor (NPR)-B, Not NPR-A, is the predominant natriuretic peptide receptor in the failing heart.
Dickey DM; Flora DR; Bryan PM; Xu X; Chen Y; Potter LR
Endocrinology; 2007 Jul; 148(7):3518-22. PubMed ID: 17412809
[TBL] [Abstract][Full Text] [Related]
35. Membrane-bound guanylate cyclase as the receptor of natriuretic peptides. A minireview.
Rambotti MG; Spreca A; Donato R
Ital J Anat Embryol; 1995; 100 Suppl 1():55-62. PubMed ID: 11322335
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis, and actions of a novel chimeric natriuretic peptide: CD-NP.
Lisy O; Huntley BK; McCormick DJ; Kurlansky PA; Burnett JC
J Am Coll Cardiol; 2008 Jul; 52(1):60-8. PubMed ID: 18582636
[TBL] [Abstract][Full Text] [Related]
37. Differential regulation of natriuretic peptide receptors on ciliary body epithelial cells.
Crook RB; Chang AT
Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):49-55. PubMed ID: 9164840
[TBL] [Abstract][Full Text] [Related]
38. CRRL269: a novel designer and renal-enhancing pGC-A peptide activator.
Chen Y; Harty GJ; Huntley BK; Iyer SR; Heublein DM; Harders GE; Meems L; Pan S; Sangaralingham SJ; Ichiki T; Burnett JC
Am J Physiol Regul Integr Comp Physiol; 2018 Mar; 314(3):R407-R414. PubMed ID: 29187381
[TBL] [Abstract][Full Text] [Related]
39. Characterization of the snake venom ligand [125I]-DNP binding to natriuretic peptide receptor-A in human artery and potent DNP mediated vasodilatation.
Singh G; Maguire JJ; Kuc RE; Skepper JN; Fidock M; Davenport AP
Br J Pharmacol; 2006 Dec; 149(7):838-44. PubMed ID: 17043672
[TBL] [Abstract][Full Text] [Related]
40. Neutral endopeptidase (CD10) is abundantly expressed in the epididymis and localized to a distinct population of epithelial cells--its relevance for CNP degradation.
Thong A; Müller D; Feuerstacke C; Mietens A; Stammler A; Middendorff R
Mol Cell Endocrinol; 2014 Jan; 382(1):234-243. PubMed ID: 24099862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
